Finanzwire Finanzwire
Basculer en Français
9979 Companies
202294 Keywords
132916 Articles
107422 Press releases
Headlines Articles Press releases Utility Therapeutics Ltd. Remove
  1. Home
  2. Companies
  3. Utility Therapeutics Ltd.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/17/2024 at 12:00, 2 years 1 month ago

    UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review

    UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com.
    UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
    Logo of Utility Therapeutics Ltd.
Accesswire
  • Published on 03/05/2026 at 13:40, 15 minutes ago

    Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

  • Published on 03/05/2026 at 13:30, 25 minutes ago

    Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend

  • Published on 03/05/2026 at 13:30, 25 minutes ago

    Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase

  • Published on 03/05/2026 at 13:00, 55 minutes ago

    Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico

  • Published on 03/05/2026 at 13:00, 55 minutes ago

    Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose

View all ACCESSWIRE
EQS Group
  • Published on 03/05/2026 at 13:43, 12 minutes ago

    Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors

  • Published on 03/05/2026 at 13:25, 30 minutes ago

    Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence

  • Published on 03/05/2026 at 13:06, 48 minutes ago

    HENSOLDT acquires Nedinsco and expands its European presence

  • Published on 03/05/2026 at 13:05, 50 minutes ago

    Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales

  • Published on 03/05/2026 at 13:00, 55 minutes ago

    Huawei Launches AI Data Platform to Bridge Models and Business Value

View all EQS
Les Echos
  • Published on 03/05/2026 at 13:20, 34 minutes ago

    Voting rights

  • Published on 03/05/2026 at 07:30, 6 hours 25 minutes ago

    Share buyback finalized

  • Published on 03/04/2026 at 23:50, 14 hours 5 minutes ago

    Total number of voting rights and shares making up the share capital at February 28, 2026

  • Published on 03/04/2026 at 18:00, 19 hours 55 minutes ago

    Disclosure of Share Capital and Voting Rights as of February 28, 2026

  • Published on 03/04/2026 at 17:45, 20 hours 10 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy